Prenetics Global Limited
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health…
1D
-8.6%
1W
-15.2%
1M
-15.9%
6M
+3.9%
YTD
+17.6%
1Y
+16.8%
2Y
+263.1%
5Y
-83.9%
10Y
–
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~2% weaker price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 20/08/2026.
PRICE TARGET LOW
US$35.00
CONSENSUS
US$43.00
MEDIAN
US$40.00
PRICE TARGET HIGH
US$54.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 15/07/2026
P/E
-4.45
P/B
3.44
EV/EBITDA
-4.13
RETURN ON EQUITY
-9.7%
NET MARGIN
-19.3%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
74.8%
FLOAT SHARES
12,783,363
AVG. DAILY VOLUME (30D)
189,109
Leogrande Hudson Blake
Lo Hoi Chun
Leogrande Hudson Blake
Rosin Brian J
Rosin Brian J
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -8.6%
Search (Google Trends)
Forums (Reddit)
See the full forum history with Pro.
Prenetics Global Limited is a company in the Consumer Defensive sector, Household & Personal Products industry, headquartered in Hong Kong SAR China.
The CEO is Sheng Wu Yeung, the company employs around 98 people.
The IPO was on 16/07/2021; the stock trades on NASDAQ under the ticker PRE.
2 analysts rate the stock, the consensus is Buy (as of 15/07/2026).
The average price target is US$43.00, ranging from US$35.00 to US$54.00, with a median of US$40.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly -2% stronger than usual.
Yes. The last dividend was US$0.06 per share, ex-date 17/02/2016, paid on 01/03/2016.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include Procter & Gamble Company, Colgate-Palmolive Company, Estée Lauder Companies, Kenvue, Kimberly-Clark, Henkel, Church & Dwight and Beiersdorf.
Clicking "Analyze stock" lets five strategies assess Prenetics Global against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.